Next Article in Journal
Introduction to the Special Issue on Clostridioides difficile Infection, Second Edition
Previous Article in Journal
Essential Oils from Southern Italian Aromatic Plants Synergize with Antibiotics against Escherichia coli, Pseudomonas aeruginosa and Enterococcus faecalis Cell Growth and Biofilm Formation
Previous Article in Special Issue
Efficacy of Short Novel Antimicrobial Peptides in a Mouse Model of Staphylococcus pseudintermedius Skin Infection
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

A Cyclic Peptide Based on Pheasant Cathelicidin Inhibits Influenza A H1N1 Virus Infection

Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Antibiotics 2024, 13(7), 606; https://doi.org/10.3390/antibiotics13070606
Submission received: 2 June 2024 / Revised: 24 June 2024 / Accepted: 26 June 2024 / Published: 28 June 2024
(This article belongs to the Special Issue Antimicrobial Activity of Bioactive Peptides and Their Derivatives)

Abstract

Influenza viruses are the leading cause of upper respiratory tract infections, leading to several global pandemics and threats to public health. Due to the continuous mutation of influenza A viruses, there is a constant need for the development of novel antiviral therapeutics. Recently, natural antimicrobial peptides have provided an opportunity for the discovery of anti-influenza molecules. Here, we designed several peptides based on pheasant cathelicidin and tested their antiviral activities and mechanisms against the H1N1 virus. Of note, the designed peptides Pc-4 and Pc-5 were found to inhibit replication of the H1N1 virus with an IC50 = 8.14 ± 3.94 µM and 2.47 ± 1.95 µM, respectively. In addition, the cyclic peptide Pc-5 was found to induce type I interferons and the expression of interferon-induced genes. An animal study showed that the cyclic peptide Pc-5 effectively inhibited H1N1 virus infection in a mouse model. Taken together, our work reveals a strategy for designing cyclic peptides and provides novel molecules with therapeutic potential against influenza A virus infection.
Keywords: antiviral peptide; influenza A virus; type I interferon; cyclic peptide antiviral peptide; influenza A virus; type I interferon; cyclic peptide

Share and Cite

MDPI and ACS Style

Pei, Y.; Chen, Z.; Zhao, R.; An, Y.; Yisihaer, H.; Wang, C.; Bai, Y.; Liang, L.; **, L.; Hu, Y. A Cyclic Peptide Based on Pheasant Cathelicidin Inhibits Influenza A H1N1 Virus Infection. Antibiotics 2024, 13, 606. https://doi.org/10.3390/antibiotics13070606

AMA Style

Pei Y, Chen Z, Zhao R, An Y, Yisihaer H, Wang C, Bai Y, Liang L, ** L, Hu Y. A Cyclic Peptide Based on Pheasant Cathelicidin Inhibits Influenza A H1N1 Virus Infection. Antibiotics. 2024; 13(7):606. https://doi.org/10.3390/antibiotics13070606

Chicago/Turabian Style

Pei, Ya**, Zhihua Chen, Ruihan Zhao, Yanxing An, Haiche Yisihaer, Chaojie Wang, Yaning Bai, Libin Liang, Lin **, and Yongting Hu. 2024. "A Cyclic Peptide Based on Pheasant Cathelicidin Inhibits Influenza A H1N1 Virus Infection" Antibiotics 13, no. 7: 606. https://doi.org/10.3390/antibiotics13070606

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop